Search results
Results From The WOW.Com Content Network
The most common side effects include nausea (feeling sick), vomiting, constipation, loss of appetite, alopecia (hair loss), headache, fatigue (tiredness), convulsions (fits), rash, neutropenia or lymphopenia (low white-blood-cell counts), and thrombocytopenia (low blood platelet counts). [5]
General constitutional upset of sleepiness or sleeplessness, generally feeling unwell, dizziness. Diarrhea, vomiting, stomach pain, feeling sick; Skin reactions of itching, rash or urticaria (hives) Rare (affects at least 1 in 10,000 people) Serious generalised allergic reactions of anaphylaxis; Fits
The most common side effects with vonicog alfa (which may affect up to 1 in 10 patients) are dizziness, vertigo (a spinning sensation), dysgeusia (taste disturbances), tremor, rapid heartbeat, deep venous thrombosis (blood clot in a deep vein, usually in the leg), hypertension (high blood pressure), hot flush, vomiting, nausea (feeling sick ...
Is there a booster shot against the XEC variant? The most recent COVID-19 vaccine should offer protection against the XEC variant, Russo says. “The most recent version of the vaccine seems to be ...
However, Dr. Lee says that deciding when to get a flu shot should hinge on how you’re feeling and whether you have a fever. When in doubt, talk to your doctor before getting vaccinated.
Nausea and or vomiting is the main complaint in 1.6% of visits to family physicians in Australia. [6] However, only 25% of people with nausea visit their family physician. [1] In Australia, nausea, as opposed to vomiting, occurs most frequently in persons aged 15–24 years, and is less common in other age groups. [6]
Once you get it, simply adhere the small patch to a clean, hairless area behind your ear ahead of your travels, per the Cleveland Clinic, and it will prevent nausea and vomiting brought on by ...
The most common side effects include vomiting, nausea (feeling sick), hypernatremia (high blood levels of sodium), hypophosphatemia (low blood levels of phosphate) and hypokalemia (low blood levels of potassium). [2] Sodium thiosulfate (Pedmarqsi) was approved for medical use in the European Union in May 2023. [2]